Digitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding

Rationale: Cystic fibrosis (CF) lung disease progresses by a combination of airway inflammation, bacterial colonization, and infection. Airway inflammation is predominantly neutrophilic and complicates airway clearance therapies through cellular debris; excessive DNA; excessive and viscous mucus; an...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Am Thorac Soc
Main Authors: Zeitlin, Pamela L., Diener-West, Marie, Callahan, Karen A., Lee, Seakwoo, Talbot, C. Conover, Pollard, Bette, Boyle, Michael P., Lechtzin, Noah
Format: Artigo
Jezik:Inglês
Izdano: American Thoracic Society 2017
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5427734/
https://ncbi.nlm.nih.gov/pubmed/28006108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201608-649OC
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki